Cynthia L. Goldenberg, Director at IMMUNOMEDICS INC (IMMU), sold 276,044 shares at $7.40 ($2.0M) on 2017-05-19, disclosed to the SEC on 2017-08-14.
Seasonal sale ($2.0M) by Director — this insider has traded IMMU in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.65 | 11,696 | $54K | 2.7% |
| 2 | $6.39 | 5,848 | $37K | 1.9% |
| 3 | $7.38 | 9,500 | $70K | 3.5% |
| 4 | $7.38 | 11,500 | $85K | 4.2% |
| 5 | $7.34 | 11,500 | $84K | 4.2% |
| 6 | $7.40 | 9,500 |
| $70K |
| 3.5% |
| 7 | $7.45 | 9,500 | $71K | 3.5% |
| 8 | $7.45 | 11,500 | $86K | 4.3% |
| 9 | $7.42 | 86,500 | $642K | 31.9% |
| 10 | $7.43 | 109,000 | $810K | 40.3% |
| Total | $7.28 avg | 276,044 | $2.0M | 100% |
| Filing → |
| IMMU | SELL | 2017-08-23 | $369K | — | Filing → |
| IMMU | SELL | 2016-06-14 | $1.6M | — | Filing → |
| IMMU | SELL | 2016-06-08 | $2.7M | — | Filing → |